CHRISTOPHER DZIOPALA: Open Payments
NPI 1386030344 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,514 in 40 payments from 14 companies in 2025. Trend: 2023 $2,636 · 2024 $2,843 · 2025 $2,514
Food & beverage: $2,514
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $696 |
| Abbott Laboratories | 5 | $525 |
| ABBVIE INC. | 10 | $359 |
| Dexcom, Inc. | 3 | $245 |
| Gilead Sciences, Inc. | 1 | $128 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Novo Nordisk Inc | 1 | $122 |
| PFIZER INC. | 1 | $100 |
| RGH Enterprises LLC | 1 | $92 |
| Exact Sciences Corporation | 2 | $43 |
Products named: FREESTYLE LIBRE 3, BREZTRI, VRAYLAR, AIRSUPRA, DEXCOM G7 GSS (161), Epclusa, Wegovy, FREESTYLE LIBRE 2.
Industry payments across FL — which companies pay providers there.
